AKT1 and cancer: Embelin is a potent small molecule inhibitor of XIAP which prevents the binding of XIAP to procaspase-9 [19] and exhibits cytotoxic effects via suppressing the activity various signaling cascades including PI3-kinase/AKT in a variety of cancer cell lines [4, 5, 21–23].